Suppr超能文献

一种用于提高溶解度的新型氨基甲基丙烯酸酯基共聚物——从自由基聚合合成到无定形固体分散体的制备与表征

A Novel Aminomethacrylate-Based Copolymer for Solubility Enhancement-From Radical Polymer Synthesis to Manufacture and Characterization of Amorphous Solid Dispersions.

作者信息

Schmied Fabian-Pascal, Bernhardt Alexander, Moers Christian, Meier Christian, Endres Thomas, Klein Sandra

机构信息

Institute of Biopharmaceutics and Pharmaceutical Technology, Department of Pharmacy, University of Greifswald, Felix-Hausdorff-Straße 3, 17489 Greifswald, Germany.

Evonik Operations GmbH, Research, Development & Innovation, Kirschenallee, 64293 Darmstadt, Germany.

出版信息

Polymers (Basel). 2022 Mar 22;14(7):1281. doi: 10.3390/polym14071281.

Abstract

The present study covers the synthesis, purification and evaluation of a novel aminomethacrylate-based copolymer in terms of its suitability for improving the solubility and in vitro release of poorly water-soluble drug compounds. The new copolymer was synthesized by solvent polymerization with radical initiation and by use of a chain transfer agent. Based on its composition, it can be considered as a modified type of dimethylaminoethyl methacrylate-butyl methacrylate-methyl methacrylate "EUDRAGIT E PO" (ModE). ModE was specifically developed to provide a copolymer with processing and application properties that exceed those of commercially available (co-)polymers in solubility enhancement technologies where possible. By varying the concentration of the chain transfer agent in the radical polymerization process, the molecular weight of ModE was varied in a range of 173-305 kDa. To evaluate the solubility-enhancing properties of ModE, a series of drug-loaded extrudates were prepared by hot melt extrusion using the novel-as well as several commercially available-(co-)polymers. These extrudates were then subjected to comparative tests for amorphousness, solubility-enhancing properties, storage stability, and drug release. Celecoxib, efavirenz, and fenofibrate were used as model drugs in all experiments. Of all the (co-)polymers included in the study, ModE with a molecular weight of 173 kDa showed the best performance in terms of desired properties and was shown to be particularly suitable for preparing amorphous solid dispersions (ASDs) of the three model drugs, which in a first set of dissolution experiments showed better release behavior under pH conditions of the fasting stomach than higher molecular weight ModE types, as well as a variety of commercially available (co-)polymers. Therefore, the results demonstrate the successful synthesis of a new copolymer, which in future studies will be investigated in more detail for universal application in the field of solubility enhancement.

摘要

本研究涵盖了一种新型氨基甲基丙烯酸酯基共聚物的合成、纯化及其评估,该共聚物旨在提高难溶性药物化合物的溶解度和体外释放性能。这种新型共聚物通过自由基引发的溶剂聚合反应,并使用链转移剂合成。基于其组成,它可被视为甲基丙烯酸二甲氨基乙酯-甲基丙烯酸丁酯-甲基丙烯酸甲酯“尤特奇E PO”(ModE)的一种改性类型。开发ModE的目的是在可能的溶解度增强技术中,提供一种具有超过市售(共)聚物加工和应用性能的共聚物。通过改变自由基聚合过程中链转移剂的浓度,ModE的分子量在173-305 kDa范围内变化。为了评估ModE的增溶性能,使用新型以及几种市售(共)聚物通过热熔挤出制备了一系列载药挤出物。然后对这些挤出物进行无定形性、增溶性能、储存稳定性和药物释放的对比测试。在所有实验中,塞来昔布、依法韦仑和非诺贝特用作模型药物。在该研究中包含的所有(共)聚物中,分子量为173 kDa的ModE在所需性能方面表现最佳,并且被证明特别适合制备这三种模型药物的无定形固体分散体(ASD),在第一组溶出实验中,其在空腹胃的pH条件下的释放行为比高分子量的ModE类型以及多种市售(共)聚物更好。因此,结果表明成功合成了一种新型共聚物,在未来的研究中将对其在溶解度增强领域的广泛应用进行更详细的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b28/9003068/cbc003fa4a8d/polymers-14-01281-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验